カテゴリー： Market Monitor Global, 世界, 医療/バイオ

細胞療法の世界市場見通し2023年-2029年

◆英語タイトル：Cytotherapy Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8446 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：67 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Cytotherapy Market 調査レポートは次の情報を含め、グローバルにおけるの細胞療法市場規模と予測を収録しています。・世界の細胞療法市場：売上、2018年-2023年、2024年-2029年
・世界の細胞療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の細胞療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「幹細胞」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

細胞療法のグローバル主要企業は、Gilead Sciences、 Novartis、 Osiris、 Vericel Corporation、 Vcanbio、 Fujifilm Cellular Dynamics、 JCR Pharmaceuticals、 Beike Biotechnology、 Golden Meditech、 Guanhao Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、細胞療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の細胞療法市場：タイプ別、2018年-2023年、2024年-2029年
世界の細胞療法市場：タイプ別市場シェア、2022年
・幹細胞、非幹細胞

世界の細胞療法市場：用途別、2018年-2023年、2024年-2029年
世界の細胞療法市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の細胞療法市場：地域・国別、2018年-2023年、2024年-2029年
世界の細胞療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における細胞療法のグローバル売上、2018年-2023年
・主要企業における細胞療法のグローバル売上シェア、2022年
・主要企業における細胞療法のグローバル販売量、2018年-2023年
・主要企業における細胞療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Gilead Sciences、 Novartis、 Osiris、 Vericel Corporation、 Vcanbio、 Fujifilm Cellular Dynamics、 JCR Pharmaceuticals、 Beike Biotechnology、 Golden Meditech、 Guanhao Biotech

*************************************************************

・調査・分析レポートの概要
細胞療法市場の定義
市場セグメント
世界の細胞療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の細胞療法市場規模
世界の細胞療法市場規模：2022年 VS 2029年
世界の細胞療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの細胞療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の細胞療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：幹細胞、非幹細胞
細胞療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
細胞療法の用途別グローバル売上・予測

・地域別市場分析
地域別細胞療法市場規模 2022年と2029年
地域別細胞療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Gilead Sciences、 Novartis、 Osiris、 Vericel Corporation、 Vcanbio、 Fujifilm Cellular Dynamics、 JCR Pharmaceuticals、 Beike Biotechnology、 Golden Meditech、 Guanhao Biotech
...

Cytotherapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
This report aims to provide a comprehensive presentation of the global market for Cytotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytotherapy. This report contains market size and forecasts of Cytotherapy in global, including the following market information:
Global Cytotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cytotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stem Cell Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cytotherapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology and Golden Meditech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cytotherapy Market Segment Percentages, by Type, 2022 (%)
Stem Cell
Non-Stem Cell
Global Cytotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cytotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Cytotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cytotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cytotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cytotherapy, market overview.
Chapter 2: Global Cytotherapy market size in revenue.
Chapter 3: Detailed analysis of Cytotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cytotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cytotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cytotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cytotherapy Overall Market Size
2.1 Global Cytotherapy Market Size: 2022 VS 2029
2.2 Global Cytotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cytotherapy Players in Global Market
3.2 Top Global Cytotherapy Companies Ranked by Revenue
3.3 Global Cytotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cytotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cytotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cytotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cytotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cytotherapy Market Size Markets, 2022 & 2029
4.1.2 Stem Cell
4.1.3 Non-Stem Cell
4.2 By Type – Global Cytotherapy Revenue & Forecasts
4.2.1 By Type – Global Cytotherapy Revenue, 2018-2023
4.2.2 By Type – Global Cytotherapy Revenue, 2024-2029
4.2.3 By Type – Global Cytotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cytotherapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Cytotherapy Revenue & Forecasts
5.2.1 By Application – Global Cytotherapy Revenue, 2018-2023
5.2.2 By Application – Global Cytotherapy Revenue, 2024-2029
5.2.3 By Application – Global Cytotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cytotherapy Market Size, 2022 & 2029
6.2 By Region – Global Cytotherapy Revenue & Forecasts
6.2.1 By Region – Global Cytotherapy Revenue, 2018-2023
6.2.2 By Region – Global Cytotherapy Revenue, 2024-2029
6.2.3 By Region – Global Cytotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cytotherapy Revenue, 2018-2029
6.3.2 US Cytotherapy Market Size, 2018-2029
6.3.3 Canada Cytotherapy Market Size, 2018-2029
6.3.4 Mexico Cytotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cytotherapy Revenue, 2018-2029
6.4.2 Germany Cytotherapy Market Size, 2018-2029
6.4.3 France Cytotherapy Market Size, 2018-2029
6.4.4 U.K. Cytotherapy Market Size, 2018-2029
6.4.5 Italy Cytotherapy Market Size, 2018-2029
6.4.6 Russia Cytotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cytotherapy Market Size, 2018-2029
6.4.8 Benelux Cytotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cytotherapy Revenue, 2018-2029
6.5.2 China Cytotherapy Market Size, 2018-2029
6.5.3 Japan Cytotherapy Market Size, 2018-2029
6.5.4 South Korea Cytotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cytotherapy Market Size, 2018-2029
6.5.6 India Cytotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cytotherapy Revenue, 2018-2029
6.6.2 Brazil Cytotherapy Market Size, 2018-2029
6.6.3 Argentina Cytotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cytotherapy Revenue, 2018-2029
6.7.2 Turkey Cytotherapy Market Size, 2018-2029
6.7.3 Israel Cytotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cytotherapy Market Size, 2018-2029
6.7.5 UAE Cytotherapy Market Size, 2018-2029
7 Cytotherapy Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Cytotherapy Major Product Offerings
7.1.4 Gilead Sciences Cytotherapy Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Cytotherapy Major Product Offerings
7.2.4 Novartis Cytotherapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Osiris
7.3.1 Osiris Company Summary
7.3.2 Osiris Business Overview
7.3.3 Osiris Cytotherapy Major Product Offerings
7.3.4 Osiris Cytotherapy Revenue in Global Market (2018-2023)
7.3.5 Osiris Key News & Latest Developments
7.4 Vericel Corporation
7.4.1 Vericel Corporation Company Summary
7.4.2 Vericel Corporation Business Overview
7.4.3 Vericel Corporation Cytotherapy Major Product Offerings
7.4.4 Vericel Corporation Cytotherapy Revenue in Global Market (2018-2023)
7.4.5 Vericel Corporation Key News & Latest Developments
7.5 Vcanbio
7.5.1 Vcanbio Company Summary
7.5.2 Vcanbio Business Overview
7.5.3 Vcanbio Cytotherapy Major Product Offerings
7.5.4 Vcanbio Cytotherapy Revenue in Global Market (2018-2023)
7.5.5 Vcanbio Key News & Latest Developments
7.6 Fujifilm Cellular Dynamics
7.6.1 Fujifilm Cellular Dynamics Company Summary
7.6.2 Fujifilm Cellular Dynamics Business Overview
7.6.3 Fujifilm Cellular Dynamics Cytotherapy Major Product Offerings
7.6.4 Fujifilm Cellular Dynamics Cytotherapy Revenue in Global Market (2018-2023)
7.6.5 Fujifilm Cellular Dynamics Key News & Latest Developments
7.7 JCR Pharmaceuticals
7.7.1 JCR Pharmaceuticals Company Summary
7.7.2 JCR Pharmaceuticals Business Overview
7.7.3 JCR Pharmaceuticals Cytotherapy Major Product Offerings
7.7.4 JCR Pharmaceuticals Cytotherapy Revenue in Global Market (2018-2023)
7.7.5 JCR Pharmaceuticals Key News & Latest Developments
7.8 Beike Biotechnology
7.8.1 Beike Biotechnology Company Summary
7.8.2 Beike Biotechnology Business Overview
7.8.3 Beike Biotechnology Cytotherapy Major Product Offerings
7.8.4 Beike Biotechnology Cytotherapy Revenue in Global Market (2018-2023)
7.8.5 Beike Biotechnology Key News & Latest Developments
7.9 Golden Meditech
7.9.1 Golden Meditech Company Summary
7.9.2 Golden Meditech Business Overview
7.9.3 Golden Meditech Cytotherapy Major Product Offerings
7.9.4 Golden Meditech Cytotherapy Revenue in Global Market (2018-2023)
7.9.5 Golden Meditech Key News & Latest Developments
7.10 Guanhao Biotech
7.10.1 Guanhao Biotech Company Summary
7.10.2 Guanhao Biotech Business Overview
7.10.3 Guanhao Biotech Cytotherapy Major Product Offerings
7.10.4 Guanhao Biotech Cytotherapy Revenue in Global Market (2018-2023)
7.10.5 Guanhao Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cytotherapy Market Opportunities & Trends in Global Market
Table 2. Cytotherapy Market Drivers in Global Market
Table 3. Cytotherapy Market Restraints in Global Market
Table 4. Key Players of Cytotherapy in Global Market
Table 5. Top Cytotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cytotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cytotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cytotherapy Product Type
Table 9. List of Global Tier 1 Cytotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cytotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cytotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cytotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Cytotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cytotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cytotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Cytotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cytotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cytotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cytotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cytotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cytotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cytotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cytotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cytotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cytotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cytotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cytotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cytotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Gilead Sciences Company Summary
Table 31. Gilead Sciences Cytotherapy Product Offerings
Table 32. Gilead Sciences Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Cytotherapy Product Offerings
Table 36. Novartis Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Osiris Company Summary
Table 39. Osiris Cytotherapy Product Offerings
Table 40. Osiris Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Osiris Key News & Latest Developments
Table 42. Vericel Corporation Company Summary
Table 43. Vericel Corporation Cytotherapy Product Offerings
Table 44. Vericel Corporation Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Vericel Corporation Key News & Latest Developments
Table 46. Vcanbio Company Summary
Table 47. Vcanbio Cytotherapy Product Offerings
Table 48. Vcanbio Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Vcanbio Key News & Latest Developments
Table 50. Fujifilm Cellular Dynamics Company Summary
Table 51. Fujifilm Cellular Dynamics Cytotherapy Product Offerings
Table 52. Fujifilm Cellular Dynamics Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Fujifilm Cellular Dynamics Key News & Latest Developments
Table 54. JCR Pharmaceuticals Company Summary
Table 55. JCR Pharmaceuticals Cytotherapy Product Offerings
Table 56. JCR Pharmaceuticals Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. JCR Pharmaceuticals Key News & Latest Developments
Table 58. Beike Biotechnology Company Summary
Table 59. Beike Biotechnology Cytotherapy Product Offerings
Table 60. Beike Biotechnology Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Beike Biotechnology Key News & Latest Developments
Table 62. Golden Meditech Company Summary
Table 63. Golden Meditech Cytotherapy Product Offerings
Table 64. Golden Meditech Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Golden Meditech Key News & Latest Developments
Table 66. Guanhao Biotech Company Summary
Table 67. Guanhao Biotech Cytotherapy Product Offerings
Table 68. Guanhao Biotech Cytotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. Guanhao Biotech Key News & Latest Developments
List of Figures
Figure 1. Cytotherapy Segment by Type in 2022
Figure 2. Cytotherapy Segment by Application in 2022
Figure 3. Global Cytotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cytotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cytotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cytotherapy Revenue in 2022
Figure 8. By Type - Global Cytotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cytotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cytotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cytotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cytotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cytotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cytotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cytotherapy Revenue Market Share, 2018-2029
Figure 16. US Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cytotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cytotherapy Revenue Market Share, 2018-2029
Figure 28. China Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cytotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cytotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cytotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Gilead Sciences Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Osiris Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Vericel Corporation Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Vcanbio Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fujifilm Cellular Dynamics Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. JCR Pharmaceuticals Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Beike Biotechnology Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Golden Meditech Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Guanhao Biotech Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 細胞療法の世界市場見通し2023年-2029年(Cytotherapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

細胞療法の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp